http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-950702994-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H9-06 |
| filingDate | 1993-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1995-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-950702994-A |
| titleOfInvention | PROTEIN KINASE INHIBITORS AND RELATED COMPOUNDS COMBINED WITH TAXOL |
| abstract | The present invention describes known and novel compounds, some of which are protein kinase inhibitors that can be complexed with taxol type compounds. Complexes of the disclosed compounds with taxol type compounds have a potent synergistic effect and the complexes are useful for treating cancer. Novel compounds and their synthesis methods are described. The compounds of the following general formula (I), wherein R 1 to R 8 are various substituents are described. |
| priorityDate | 1992-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.